Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9301)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2021 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Berkovic MC, Mikulic D, Bilic-Curcic I, Mrzljak A. How far along are we in revealing the connection between metformin and colorectal cancer? World J Gastroenterol 2021; 27(14): 1362-1368 [PMID: 33911461 DOI: 10.3748/wjg.v27.i14.1362] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i14/1362.htm |
| Number | Citing Articles |
| 1 |
Antonia-Therese Kietaibl, Peter Fasching, Karl Glaser, Alexander H. Petter-Puchner. New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.828649
|
| 2 |
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, Marc Machaalani, Rashad Nawfal, Gianfranco Bittar, Hisham F. Bahmad, Nizar Bitar. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers 2022; 14(9): 2105 doi: 10.3390/cancers14092105
|
| 3 |
Barbora Salovska, Erli Gao, Sophia Müller‐Dott, Wenxue Li, Carlos Chacon Cordon, Shisheng Wang, Aurelien Dugourd, George Rosenberger, Julio Saez‐Rodriguez, Yansheng Liu. Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities. Clinical and Translational Medicine 2023; 13(2) doi: 10.1002/ctm2.1179
|
| 4 |
Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca, Mercedes Nadal-Serrano. Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies. Biology 2024; 13(5): 302 doi: 10.3390/biology13050302
|
| 5 |
Jan Dimberg, Levar Shamoun, Kalle Landerholm, Dick Wågsäter. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer. World Journal of Gastroenterology 2022; 28(19): 2148-2151 doi: 10.3748/wjg.v28.i19.2148
|
| 6 |
I. V. Druk, E. A. Lyalyukova, E. A. Fadeeva. Metformin in the prevention of colorectal cancer with diabetes mellitus. Experimental and Clinical Gastroenterology 2022; (9): 161 doi: 10.31146/1682-8658-ecg-205-9-161-170
|
| 7 |
Maria Inês Canha, Gonçalo Ramos, Rita Prata, Pedro Lages Martins, Marta Viúla Ramos, João Coimbra. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?. Journal of Gastrointestinal Cancer 2024; 55(1): 435 doi: 10.1007/s12029-023-00989-2
|
| 8 |
Yuan-Ling Tang, Dan-Dan Li, Jia-Yu Duan, Lei-Ming Sheng, Xin Wang. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments. World Journal of Gastroenterology 2023; 29(6): 926-948 doi: 10.3748/wjg.v29.i6.926
|
| 9 |
V.F. Levshin, N.I. Slepchenko. Primary prevention of colorectal cancer and technologies for its implementation into practical health care. Russian Journal of Preventive Medicine 2024; 27(6): 111 doi: 10.17116/profmed202427061111
|